Bromodomain‐Containing Protein 4 in Ischemia‐Reperfusion Injury: Mechanisms, Preclinical Evidence, and Translational Challenges
Cell Biology International · 2026-10 · 50 (10)
DOI: 10.1002/cbin.70223 ↗At a glance
Übersichtsarbeit in Cell Biology International, published online on 2026-10-14. Written by Namrata Vadak and 1 co-authors. Institution: Department of Pharmacology, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Mumbai, India. Major MEDLINE topics: Reperfusion Injury, Transcription Factors, Cell Cycle Proteins, Nuclear Proteins. 135 references. Funded by: Department of Science and Technology (DST).
Abstract (original language)
Ischemia reperfusion (IR) injury is a major contributor to tissue damage and organ dysfunction following ischemic events and clinical interventions such as thrombolysis, revascularization, and transplantation, yet effective pharmacological strategies to limit this injury remain limited. Bromodomain‐containing protein 4 (BRD4), an epigenetic reader that recognizes acetylated lysine residues to drive super‐enhancer‐associated transcription. Upregulated BRD4 has emerged as a key regulator of the inflammatory, endothelial, and cell death pathways underlying post‐IR injury pathophysiology. Preclinical evidence across cerebral, cardiac, renal, and hepatic IR injury models indicates that BRD4 hyperactivation amplifies NFκB‐dependent inflammatory signaling, while its pharmacological or genetic inhibition confers substantial tissue protection. This review synthesizes current mechanistic understanding of BRD4 in IR injury pathogenesis, evaluates emerging BET/BRD4‐targeted therapeutic strategies, and outlines key translational challenges for advancing epigenetic pharmacology toward clinical application in IR‐associated disorders.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pharmacology, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Mumbai, India.
ORCID profiles: Namrata Vadak, Lokesh Kumar Bhatt
Funding
- Department of Science and Technology (DST)
Cite
APA
Vadak, N., & Bhatt, L. K. (2026). Bromodomain‐Containing Protein 4 in Ischemia‐Reperfusion Injury: Mechanisms, Preclinical Evidence, and Translational Challenges. Cell Biology International, 50(10). https://doi.org/10.1002/cbin.70223
Vancouver
Vadak N, Bhatt LK. Bromodomain‐Containing Protein 4 in Ischemia‐Reperfusion Injury: Mechanisms, Preclinical Evidence, and Translational Challenges. Cell Biology International. 2026;50(10). doi:10.1002/cbin.70223
BibTeX
@article{Vadak2026,
author = {Vadak, Namrata and Bhatt, Lokesh Kumar},
title = {Bromodomain‐Containing Protein 4 in Ischemia‐Reperfusion Injury: Mechanisms, Preclinical Evidence, and Translational Challenges},
journal = {Cell Biology International},
year = {2026},
volume = {50},
number = {10},
doi = {10.1002/cbin.70223}
}
EUVIMED